胜游亚洲(China)集团公司亚洲胜游

Product Profile
胜游亚洲(China)集团公司

Xiangke

  • Specification50mg
  • Therapeutic fieldHematological neoplasms
  • Dosage formTablets
  • Approval numberSFDA approval number H20052083
  • Executive standardYBH08032009
亚洲胜游